{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Red blood cells count decreased]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptididase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Leukopenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Neutropenia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, AST increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, ALT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, GGT increase]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hypocalcemia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Hyponatremia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Nausea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Vomiting]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['33']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Diarrhea]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Abdominal pain]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Oral mucositis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dyspepsia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Dysgeusia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Anorexia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Alopecia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 6]",
                    "[AE, Fatigue]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Pneumonitis]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Peripheral sensory neuropathy]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Arthralgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, Myalgia]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Treatment": "Dasatinib",
                    "Dose Level": "mg",
                    "n": "number of patients",
                    "AE": "adverse event",
                    "G": "grade",
                    "AST": "aspartate aminotransferase",
                    "ALT": "alanine aminotransferase",
                    "GGT": "gamma-glutamyl transpeptidase",
                    "LVEF": "left ventricular ejection fraction"
                },
                "measures": "[Treatment, Dasatinib]",
                "outcomes": [
                    "[Dose Level, mg]",
                    "[n, 4]",
                    "[AE, LVEF decrease]",
                    "[G, G1]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 23,
    "total_ground_truth_claims": 126,
    "number_of_matches": 10
}